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Summary
 
Development of effectors from naive CD4 cells occurs in two stages. The early stage involves
activation and limited proliferation in response to T cell receptor (TCR) stimulation by antigen
and costimulatory antigen presenting cells, whereas the later stage involves proliferation and
differentiation in response to growth factors. Using a TCR-transgenic (Tg
 
1
 
) model, we have
examined the effect of aging on effector generation and studied the ability of 
 
g
 
c signaling cy-
tokines to reverse this effect. Our results indicate that responding naive CD4 cells from aged
mice, compared with cells from young mice, make less interleukin (IL)-2, expand poorly be-
tween days 3 to 5, and give rise to fewer effectors with a less activated phenotype and reduced
ability to produce cytokines. When exogenous IL-2 or other 
 
g
 
c signaling cytokines are added
during effector generation, the Tg
 
1
 
 cells from both young and aged mice proliferate vigor-
ously. However, IL-4, IL-7, and IL-15 all fail to restore efficient effector production. Only ef-
fectors from aged mice generated in the presence of IL-2 are able to produce IL-2 in amounts
equivalent to those produced by effectors generated from young mice, suggesting that the ef-
fect of aging on IL-2 production is reversible only in the presence of exogenous IL-2.
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g
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T
 
he in vitro generation of CD4 T cell effectors from
naive resting T cells has been extensively described,
and many of the factors involved in this response have been
defined (1). Naive CD4 cell activation requires TCR stim-
ulation with peptide Ag bound to MHC class II on an
APC as well as ligation of T cell coreceptors by costimula-
tory ligands on the APC (2–7). In vitro, this stimulation in-
duces IL-2 production, which then drives proliferation of
activated T cells and the differentiation of these cells into
effectors. It has been proposed that in vitro effector devel-
opment involves two steps (8, 9), the first step being a
TCR-dependent response to Ag and the second step, IL-2
driven expansion and differentiation to effectors. In vitro,
effectors are defined as highly differentiated, activated cells
able to produce high levels of cytokines rapidly upon re-
stimulation, even in the absence of costimulation. This
confers upon effectors the ability to produce cytokines in
response to nonprofessional APCs. The key characteristic
that distinguishes fully differentiated effectors from acti-
vated CD4 T cells that have not yet reached this stage is the
production of high levels of cytokines other than IL-2.
Adequate IL-2 secretion by naive T cells is essential, as
effector development requires IL-2 at several crucial stages.
When isolated CD4 cells are cultured in vitro, the initial
amount of IL-2 produced upon T cell stimulation may de-
termine the extent of clonal expansion, because IL-2 is the
only cytokine produced in these cultures that can drive
CD4 T cell cycle progression. Therefore, the size of the ef-
fector population is closely linked to the levels of IL-2
present, as indicated by results from our laboratory (9). IL-2
is also required for the efficient differentiation of respond-
ing CD4 T cells into effectors secreting high titers of other
cytokines (9). Once effectors are generated, IL-2 promotes
their expansion and is required for their survival as long as
they remain activated (1, 10, 11). In the absence of IL-2,
effectors rapidly undergo apoptosis. As IL-2 is critical for
the generation, expansion, and survival of effector CD4
cells, the reduction in IL-2 that has been reported (12–15)
in the aged could lead to inadequate effector cell develop-
ment. Perhaps paradoxically, IL-2 is also implicated in driv-
ing effector CD4 cells to apoptosis (16), a result we inter-
pret as part of the differentiative effect of IL-2 (11).
In aged individuals, two of the most significant defects in
CD4 T cell function are a decline in the frequency of
CD4
 
1
 
 T cells producing IL-2 and a decreased expression of
IL-2Rs (17, 18). There is also evidence of a decrease in the 
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early events of signal transduction and decreased cellular
proliferation in response to TCR stimulation in both the
absence and presence of costimulation (19–22), but this
may be a defect confined to the Ag-experienced T cell
population (19). Using a TCR-transgenic (Tg)
 
1
 
 mouse
model, we have previously shown a defect in IL-2 produc-
tion by naive CD4 cells from aged AND TCR-Tg mice
(
 
.
 
13 mo old) responding to both specific Ag (pigeon cyto-
chrome c peptide fragment 88–104 [PCCF]) and anti-
CD3/anti-CD28 stimulation (23, 24). In this report, we
show that one effect of decreased IL-2 production by aged
naive CD4 T cells is indeed greatly diminished late phase
effector expansion and differentiation to effectors. We find,
however, that this defect can be corrected by the addition
of exogenous IL-2 but that other 
 
g
 
c signaling cytokines
only partially reverse the defects. This indicates that the
aged cells are capable of responding normally to IL-2 and
that even the loss of IL-2 production is reversible. It also
indicates that only IL-2, and not other 
 
g
 
c-binding cyto-
kines, can correct the defect found in naive CD4 cells in
aged animals. Thus, defects in naive CD4 T cells in aged
animals might be overcome by strategies inducing greater
IL-2 availability, leading to vigorous primary responses.
 
Materials and Methods
 
Animals.
 
AND H-2
 
k/k
 
 TCR-Tg mice were bred from a
C57BL/6 
 
3
 
 SJL founder, provided by Dr. S. Hedrick (Univer-
sity of California, San Diego, CA), by successive backcrosses
(12N) onto the B10.Br background. These mice express a V
 
b
 
3/
V
 
a
 
11 TCR transgene that recognizes PCCF in the context of I-E
 
k
 
.
The mice were housed at either the animal facilities at the
Trudeau Institute or the Scripps Research Institute (La Jolla, CA)
until their use at 2–4 (young) and 13–16 mo old (aged). Mice
with evidence of gross pathology were excluded from the study.
 
Cell Isolations.
 
Each experiment was performed at least two
times with pooled spleens and peripheral lymph nodes from two
young and two or three aged mice. The isolation of spleen cells
enriched for CD4 cells has been described previously (23). In
brief, the cells were passed through a nylon wool column or a
mouse CD4 enrichment column (R & D Systems, Inc.), and the
nonadherent cells were stained with Cy-Chrome–anti-CD4,
FITC–anti-V
 
a
 
11, and PE–anti-V
 
b
 
3 or APC–anti-CD4, PE–
anti-V
 
a
 
11, biotin–anti-V
 
b
 
3, and streptavidin red613. The
CD4
 
1
 
V
 
b
 
3
 
1
 
V
 
a
 
11
 
1
 
 cells were sorted using either FACStar
 
PLUS™
 
or FACSVantage™ (Becton Dickinson). Alternatively, small rest-
ing CD4 cells were prepared as described (25) by passage over
nylon wool and antibody and complement depletion of CD8
 
1
 
and class II
 
1
 
 cells followed by Percoll gradient separation. Both
methods of CD4 enrichment yielded similar results in all experi-
ments.
 
Immunofluorescent Staining.
 
All staining was done at 4
 
8
 
C in
PBS with 1% BSA and 0.1% NaN
 
3
 
. The following antibodies and
fluorescent reagents were used: Cy-Chrome– and APC–anti-
CD4 (clone RM4-5; PharMingen), FITC–anti-CD44 (clone
IM7), FITC–anti-CD62L (clone Mel 14), FITC– and PE–anti-
 
V
 
a
 
11 (clone RR8-1; PharMingen), PE– and biotin–anti-V
 
b
 
3
(clone KJ25; PharMingen), FITC–anti-CD25 (IL-2R 
 
a
 
 chain;
clone PC61), FITC–anti-CD122 (IL-2R 
 
b
 
 chain; clone 5H4),
biotin–anti-CD132 (common 
 
g 
 
[
 
g
 
c] chain; clone 4G3) streptavi-
din red613 (GIBCO BRL), streptavidin Per-CP (Becton Dick-
inson), streptavidin–PE, and streptavidin–FITC (both from
Southern Biotechnology). All isotype control antibodies were
purchased from PharMingen: FITC–hamster Ig, FITC–rat IgG1,
FITC–rat IgG2a, and FITC–rat IgG2b. Flow cytometry was car-
ried out using FACScan™, FACStar
 
PLUS™
 
, or FACSCalibur™
flow cytometers, and the data were analyzed with CELLQuest™
software (all from Becton Dickinson).
 
Carboxy-Fluorescein Succinimidyl Ester Labeling.
 
Naive cell
populations were stained with the dye CFSE (carboxy-fluorescein
succinimidyl ester; Molecular Probes, Inc.) as previously described
(26). In brief, cells were resuspended in PBS at 5 
 
3 
 
10
 
7
 
 cells/ml.
CFSE (1 mM stock) was added to the cell suspension at 1:250 and
incubated in a 37
 
8
 
C water bath for 13 min. Cells were then washed
two times, recounted, and cultured as described below.
 
Cell Culture and Effector Generation.
 
Cells were cultured in
RPMI 1640 (GIBCO BRL) supplemented with penicillin (200
 
m
 
g/ml), streptomycin (200 
 
m
 
g/ml), glutamine (4 mM), 2-ME
(50 
 
m
 
M), Hepes (10 mM), and 8% fetal bovine serum (Intergen).
DCEK-ICAM, a fibroblast cell line that expresses B7.1 constitu-
tively and is stably transfected with intercellular adhesion mole-
cule (ICAM)-1 and class II MHC (I-E
 
k
 
) molecules, was used as
APC at 2:1 T cell/APC. These cells do not express other costim-
ulatory molecules such as lymphocyte-associated function antigen
(LFA) type 1, CD48, or heat-stable Ag.
Recombinant murine cytokines IL-2, IL-4, IFN-
 
g
 
, and IL-5
were obtained from culture supernatant of X63.Ag8-653 cells
transfected with cDNA for the respective cytokines (27). Re-
combinant murine IL-12 was a gift of Dr. Stanley Wolf (Genetics
Institute, Cambridge, MA). For experiments involving the addi-
tion of cytokines to T cell proliferation assays, IL-2 (35 U/ml),
IL-4 (25 ng/ml), IL-7 (950 U/ml; a gift from Dr. Albert Zlotnik,
DNAX, Palo Alto, CA), and human IL-15 (60 ng/ml; R & D
Systems, Inc.) were added at the initiation of the cultures.
CD4 effectors were generated by culturing Tg
 
1
 
 CD4 cells (2 
 
3
 
10
 
5
 
 cells/ml) with 5 
 
m
 
M PCCF and mitomycin c–treated (100
 
m
 
g/ml for 30 min at 37
 
8
 
C) DCEK-ICAM cells (2:1 T cell/APC)
in the presence of polarizing cytokines. Th1 effectors were gen-
erated with IL-2 (80 U/ml), IL-12 (2 ng/ml), and anti-IL4
(11B11; 10 
 
m
 
g/ml). Th2 effectors were generated with IL-2, IL-4
(200 U/ml), and anti–IFN-
 
g
 
 (XMG1.2; 10 
 
m
 
g/ml). IL-2 effec-
tors were generated with IL-2 (80 U/ml). “No cytokine” effec-
tors were generated in the presence of PCCF/DCEK-ICAM
alone. Day 4 effectors were used in all experiments and were re-
stimulated in 1-ml cultures with PCCF/DCEK-ICAM; 24-h su-
pernatants were collected and assayed for cytokine secretion.
 
DNA Synthesis. 
 
[
 
3
 
H]thymidine incorporation assays to de-
tect DNA synthesis were performed in 96-well plates. Varying
numbers of Tg
 
1
 
 CD4 cells (10
 
4
 
–5 
 
3
 
 10
 
5 
 
cells/ml; 0.2-ml cul-
tures) were incubated along with DCEK-ICAM cells and 5 
 
m
 
M
PCCF for 3 d. The cultures were pulsed for the last 16 h with 0.4
 
m
 
Ci [
 
3
 
H]TdR (6.7 Ci/mmol; NEN Research Products), har-
vested, and counted on a Wallac 1205 Betaplate counter.
 
Cytokine Detection.
 
Culture supernatants collected after 24 h
of culture or as indicated and were assayed for the presence of IL-2
in a bioassay with NK-3 cells and for IL-4, IL-5, and IFN-
 
g
 
 by
ELISA as previously described (23). IL-4 and IFN-
 
g
 
 concentra-
tions are expressed in ng/ml; IL-2 and IL-5 concentrations are
expressed in U/ml. 1 U of IL-2 is equal to 1.2 ng.
 
1
 
Abbreviations used in this paper:
 
 ICAM, intercellular adhesion molecule;
PCCF, pigeon cytochrome c peptide fragment 88–104; Tg, transgenic. 
1015
 
Haynes et al.
 
Statistical Analysis.
 
Differences in IL-2 production between
young and aged effector populations were analyzed by paired
Student’s 
 
t
 
 test. Values of
 
 P 
 
, 
 
0.05 were considered significant.
 
Intracellular Cytokine Staining.
 
Cytokine production by effec-
tors was detected by intracellular cytokine staining as previously
described (28, 29). Effectors (5 
 
3
 
 10
 
5
 
 per milliliter) were restim-
ulated overnight with DCEK-ICAM cells (2:1 T cell/APC) with
or without 5 
 
m
 
M PCCF. Brefeldin A (Epicentre Technologies;
10 
 
m
 
g/ml final concentration) was added 2 h after culture initia-
tion. 16 h later, cells were collected and surface stained for CD4
and Tg
 
1
 
 expression as described above. The cells were then di-
vided into two tubes, washed, and fixed in 75 
 
m
 
l 4% paraformal-
dehyde plus 25 
 
m
 
l PBS containing 10 
 
m
 
g/ml Brefeldin A and in-
cubated for 20 min at room temperature. The tubes were washed
once with PBS, resuspended in 50 
 
m
 
l saponin buffer (PBS con-
taining 1% fetal bovine serum, 0.1% NaN
 
3
 
, and 0.1% saponin,
pH 7.4–7.6) containing anti–mouse IL-2–FITC (clone S4B6;
PharMingen) or isotype control (FITC–IgG2a; PharMingen) and
incubated for 30 min at room temperature. All samples were then
washed with PBS and analyzed on a FACScan™ or FACSCali-
bur™ cytometer.
 
Results
 
To analyze the impact of the low IL-2 levels produced
by naive CD4 cells from aged mice and to determine
whether the defects could be reversed simply by providing
IL-2, we used the AND TCR-Tg model to follow effector
generation and the function and phenotype of the effectors
generated in detail. As almost all Tg
 
1
 
 cells are naive and
because we used peptide Ag plus exogenous fibroblast
APCs to stimulate effector generation, we can assess the in-
trinsic defect(s) due to age on naive T cell responses with-
out the complications of age effects on other T cells or
APCs.
 
Effect of Decreased IL-2 Production on Late Phase Proliferation
of Tg
 
1
 
 CD4 Cells from Aged Mice.
 
We have previously
shown that when naive young and aged Tg
 
1
 
 CD4 cells
were stimulated with PCCF and DCEK-ICAM, the young
cells synthesized DNA at a higher rate in a 3-d [
 
3
 
H]TdR
incorporation assay (23). To pinpoint when the response of
aged naive CD4 T cells becomes defective, similar numbers
(2 
 
3
 
 10
 
5
 
) of young and aged naive Tg
 
1
 
 CD4 cells were
stimulated with PCCF/DCEK-ICAM, and the number of
cells on each day of a 5-d culture was determined (Fig. 1
A). Both young and aged Tg
 
1
 
 CD4 populations expanded
at a similar rate up to day 3 (early phase proliferation). After
day 3, the young cells showed a large burst of expansion
that was not seen in the aged cultures (late phase prolifera-
tion). This burst of expansion resulted in a greatly increased
number of cells by days 4 and 5 in the young cultures when
compared with the aged cultures.
We suspected that this lack of late phase proliferation of
the aged cultures could potentially be attributed to de-
creased IL-2 production in these cultures. Fig. 1 B shows
the IL-2 recovered in supernatants of young and aged cul-
tures on each day. The young cultures contain large quan-
tities (
 
z
 
3,000 U/ml) of IL-2 on days 1 and 2 that is then
consumed by day 3, just as the cells begin to undergo rapid
expansion. In contrast, the supernatants of cultures of aged
CD4 T cells contain only small quantities of IL-2 (
 
,
 
500
U/ml), and expansion does not continue beyond day 3,
supporting the concept that availability of IL-2 may be the
critical factor in driving later expansion.
The decreased late phase proliferation of aged cells can
also be visualized by labeling with the dye CFSE. CFSE is
distributed equally between cells upon each cell division,
resulting in the sequential halving of fluorescence intensity
with each round of division. This sequential loss of fluores-
cence is visualized as distinct peaks when analyzed by flow
cytometry (26). Fig. 1 C shows a kinetic analysis of young
and aged CFSE-labeled Tg
 
1
 
 CD4 cells stimulated with Ag
plus APC. On days 1–3, responding CD4 cells from both
young and aged populations have undergone similar num-
bers of cell divisions, as shown by similar CFSE fluores-
cence profiles. On day 1, no divisions have yet occurred;
on day 2, both young and aged populations show three
peaks of division; and on day 3, both show four peaks of
division. Importantly, these profiles also show that all, not
just a subset, of both the young and aged Tg
 
1
 
 CD4 cells
Figure 1. Kinetics of decreased expansion and IL-2 pro-
duction by aged Tg1 CD4 cells. Tg1 CD4 cells from
young (d) and aged (s) mice (2 3 105 cells/well) were
stimulated with DCEK-ICAM APCs at 2:1 T cell/APC
and 5 mM PCCF in a 24-well plate. At each time point,
cell counts were performed (A) and supernatants were col-
lected and assayed for IL-2 in a bioassay (B). Data is repre-
sentative of five experiments. (C) Tg1 CD4 cells (2 3 105
cells/ml) from young (open histograms) and aged (shaded
histograms) mice were labeled with the dye CFSE and then
stimulated with DCEK-ICAM APCs at 2:1 T cell/APC
and 5 mM PCCF in a 24-well plate. At each time point,
cells were collected and assayed for CFSE expression on a
flow cytometer. Each histogram is gated on Vb31CD41
propidium iodide–negative cells. Data is representative of
three experiments.1016 IL-2 Can Reverse the Defect in Effector T Cells from Aged TCR-Tg Mice
undergo several rounds of division in response to stimula-
tion. If no Ag is present, neither young nor aged Tg1 CD4
cells divide (i.e., profile remains a single peak with high
levels of CFSE staining; data not shown). This data suggests
that all of the aged naive Tg1 CD4 cells are capable of
being activated to respond and divide. On days 4 and 5,
the recovered cells from cultures of young naive CD4 cells
continue to divide (up to six peaks of division), whereas the
aged cells seem to stop dividing after day 3 (day 4 and 5
profiles look very similar to those of day 3). These two ad-
ditional cell divisions in the young population translate the-
oretically into a fourfold greater expansion, as is seen in Fig.
1 A. These results further confirm the observation that
both young and aged Tg1 CD4 cells can initially proliferate
(days 1–3) in response to Ag stimulation, but the aged cells
are unable to sustain late phase proliferation.
Addition of IL-2 Restores Late Phase Expansion of Tg1
CD4 Cells from Aged Mice. As IL-2 levels were signifi-
cantly decreased in the cultures of aged Tg1 CD4 cells, we
examined the ability of aged Tg1 CD4 cells to expand in
the presence of exogenous IL-2. As shown in our previous
experiments, young CD4 cells synthesized DNA at a two-
fold higher rate on day 3 than aged cells (as measured by
[3H]TdR incorporation) when no exogenous IL-2 was
added (Fig. 2 A, filled symbols). When IL-2 was added on
day 0 to the Ag-stimulated cultures of naive young and
aged CD4 cells, both effector populations incorporated ra-
diolabel to the same extent (Fig. 2 A, open symbols). Fig. 2
B shows a kinetic analysis of cell counts from young and
aged Tg1 CD4 cell cultures with and without exogenous
IL-2 through day 5. As in the experiment shown in Fig. 1
A, all cultures expanded similarly through day 3. On days 4
and 5, both young and aged cells cultured with IL-2 ex-
panded to the same extent, as did young cells cultured with
Ag/APC alone. Only the aged Tg1 CD4 cells cultured
without added IL-2 showed greatly reduced expansion.
These results indicate that the aged Tg1 CD4 cells are ca-
pable of proliferating in response to Ag in a manner com-
parable to young cells if they are provided with adequate
amounts of exogenous IL-2. This suggests that there is no
defect in signaling through the IL-2R in these aged naive T
cells.
Effect of Other gc Signaling Cytokines. As IL-2 can in-
duce naive aged Tg1 cells to proliferate and differentiate
like young cells, we examined the effect of other common
receptor  g chain signaling cytokines on proliferation of
young and aged cells to determine if the important compo-
nents of IL-2 signaling were related only to gc or unique to
the IL-2R chains. IL-2, IL-4, IL-7, and IL-15 were titrated
over a broad range to determine the concentration for op-
timal proliferation in our assay (data not shown). The opti-
mal doses were then added to cultures of young and aged
naive CD4 T cells, and [3H]TdR incorporation was deter-
mined at day 4. Fig. 3 A, like the experiment shown in Fig.
2, shows that aged cells are dividing less but that addition of
exogenous IL-2 can induce aged Tg1 cells to synthesize
DNA to the same extent as young cells. IL-15 and IL-4 can
induce similarly high levels (greater than threefold) of
DNA synthesis of aged cells as are observed with IL-2. IL-7
can also somewhat enhance proliferation (about twofold) of
aged cells but has little effect on young cells. The expansion
and IL-2 production of young and aged effectors generated
in the presence of these cytokines was also examined. Fig. 3
B shows the fold expansion of young and aged cells from
day 0 to 4 of culture. Young cells expanded two to three
times as much as aged cells when no cytokines were added,
Figure 2. Addition of IL-2 re-
stores the proliferative capacity of
aged Tg1 CD4 cells. (A)  3-d
[3H]TdR incorporation assay of
young (circles) and aged (squares)
Tg1 CD4 cells stimulated with
DCEK-ICAM APCs and 5 mM
PCCF with (open symbols) and
without (filled symbols) exoge-
nous IL-2. [3H]TdR was added
for the last 16 h of culture. Data
is representative of three experi-
ments. (B) Tg1 CD4 cells from
young (circles) and aged (squares)
mice were stimulated with
DCEK-ICAM APCs at 2:1 T
cell/APC and 5 mM PCCF with
(open symbols) or without (filled
symbols) exogenous IL-2 in a 24-
well plate. At each time point,
cell counts were performed. Data
is representative of three experi-
ments.
Figure 3. Enhancement of pro-
liferation of aged naive Tg1 CD4
cells by gc signaling cytokines.
(A) Optimum concentrations of
IL-2 (35 U/ml), IL-4 (25 ng/
ml), IL-7 (950 U/ml), and IL-15
(60 ng/ml) were added at the ini-
tiation of cultures of young and
aged naive Tg1 cells (2 3 104/
well) with DCEK-ICAM APCs at
2:1 T cell/APC and 5 mM PCCF
in 96-well plates. Cultures were
pulsed with [3H]TdR on day 3
and harvested 18 h later. Data
presented is mean of triplicates 6
SE and is representative of two
experiments. (B) Fold expansion
of young and aged day 4 Tg1
CD4 effectors generated with
DCEK-ICAM APCs (2:1 T cell/
APC) and PCCF without added
cytokines (NONE) or optimal
concentrations of IL-2, IL-4, IL-7,
or IL-15. Data presented is mean
of three separate experiments 6
SE. (C) IL-2 production by
young and aged Tg1 CD4 effectors from B. On day 4, 2.5 3 105 effectors
were restimulated for 24 h with DCEK-ICAM and PCCF. Supernatants
were assayed for IL-2 content (expressed in units per milliliter); Data pre-
sented is the mean 6 SE of the number of experiments (n). *Statistically
significant difference between the young and aged populations (P ,
0.05).1017 Haynes et al.
whereas expansion of both young and aged cells was equiv-
alent when IL-2 was present. IL-4, IL-7, and IL-15 also
augment the expansion of aged cells to some extent. IL-4,
however, also enhances young CD4 T cell expansion so
that young cell expansion remained greater than that of
aged CD4 T cells. The effect of IL-15 on expansion was
equivalent to that of IL-2.
Because the most important outcome of the primary
CD4 T cell response is the generation of effectors, we also
examined the function of recovered effectors by assaying
for IL-2 production upon restimulation with Ag/APC. Fig.
3 C shows mean 6 SE of IL-2 secretion from all experi-
ments performed, and Fig. 4 shows a representative experi-
ment with both intracellular staining and cytokine secre-
tion. IL-2 is the only cytokine that can cause an increase in
IL-2 production by aged effectors to the levels seen for
young cells. IL-4, IL-7, and IL-15 have little or no enhanc-
ing effect on IL-2 production by aged effectors. As IL-4
causes differentiation to a Th2 cytokine pattern, the effect
of IL-4 on IL-2 production is negative in young as well as
aged CD4 T cells. Despite the ability of IL-7 and IL-15 to
restore proliferation, neither cytokine restores levels of IL-2
production by the aged cells to those achieved by the
young CD4 T cells. These results suggest that IL-2 causes
generation of effectors both by inducing proliferation and,
via a separate mechanism, upregulation of IL-2R expres-
sion, whereas IL-4, IL-7, and IL-15 can support prolifera-
tion but not all aspects of further differentiation.
Phenotype of Young and Aged Tg1 CD4 Cells. We also
examined the cell surface phenotype of effectors generated
from Tg1 CD4 cells of young and aged mice in the ab-
sence of exogenous cytokines (no cytokine effectors) and
presence of exogenous IL-2, IL-4, IL-7, or IL-15 in addi-
tion to Ag/APC. Previously, we reported (23) that the Tg1
CD4 cells obtained from both aged and young mice ex-
press a naive phenotype (Fig. 5 A, bottom), i.e., they ex-
press low levels of CD44 and high levels CD62L (L-selec-
tin) and do not express CD25 (IL-2Ra). As shown in
Fig. 5 A, the aged no cytokine effectors (Fig. 5,
shaded histograms) express a partially activated phenotype
(CD44hiCD62LhiCD25lo) by day 4 after stimulation, whereas
the young no cytokine effectors (Fig. 5, open histograms)
express a more differentiated phenotype (CD44hiCD62Llower
CD25hi). The addition of IL-2 at the initiation of the day 4
cultures produced IL-2 effectors from aged and young mice
that expressed a similar and fully differentiated activated
phenotype (CD44hiCD62LlowerCD25hi). This again sup-
ports the role of IL-2 in the full differentiation to an effec-
tor stage (9). Both young and aged IL-4 effectors showed a
more pronounced downregulation of CD62L compared
with the other effectors, also consistent with a more differ-
entiated state. But IL-4, IL-7, and IL-15 cannot induce up-
regulation of CD25 on the aged effectors. Therefore, effec-
tors that were generated under conditions where the level
of IL-2 was limiting (aged no cytokine effectors and IL-4,
IL-7, and IL-15 effectors) expressed lower levels of CD25,
whereas effectors that were generated under conditions
where IL-2 was not limiting, either due to the adequate
production of IL-2 by the effectors (all groups of young ef-
fectors) or the addition of exogenous IL-2 to the cultures
(aged IL-2 effectors), expressed high levels of CD25 with
no apparent age-related differences.
To further investigate IL-2R expression, we examined
the expression of all three chains of the receptor. Fig. 5 B
shows IL-2Ra, -b, and -gc chain expression on young and
aged no cytokine and IL-2 effectors. As shown in Fig. 5 A,
a chain (CD25) expression on aged no cytokine effectors is
lower than on young no cytokine effectors and is upregu-
lated on the aged effectors when they are provided with
exogenous IL-2. There are no age-related differences in b
(CD122) or g chain (CD132) expression on either no cy-
tokine or IL-2 effectors.
Cytokine Production by Young and Aged Tg1 Th1 and Th2
CD4 Effectors. To further evaluate the functional impact
of aging, we examined whether naive CD4 T cells from
aged mice could become polarized effectors in the presence
of polarizing cytokines and blocking antibodies. Polarized
Th1 and Th2 effector populations can be generated from
naive Tg1 CD4 cells in vitro by the addition of cytokines
and anticytokine blocking antibodies in addition to Ag and
APC. For optimum polarization, Th1 effectors require IL-2,
IL-12, and anti-IL-4, whereas Th2 effectors require IL-2,
Figure 4. Intracellular cytokine staining of
young and aged effectors. Effectors were gener-
ated from young (top) and aged (bottom) Tg1
CD4 cells with DCEK-ICAM APCs (2:1 T
cell/APC) and PCCF alone (NO CYTOKINE
EFFECTORS) or with optimum concentra-
tions of added exogenous IL-2, IL-4, IL-7, or
IL-15. On day 4, 5 3 105 effectors were restim-
ulated for 16 h with DCEK-ICAM and PCCF.
Brefeldin A was added 2 h after culture initia-
tion for intracellular staining; parallel cultures
generated supernatants that were assayed for IL-2
content (expressed in U/ml). Shaded histo-
grams represent anti–IL-2 FITC staining for
Tg1 CD4 gated effectors; dotted lines represent
isotype controls for the anticytokine antibodies.
Data is representative of three experiments.1018 IL-2 Can Reverse the Defect in Effector T Cells from Aged TCR-Tg Mice
IL-4, and anti–IFN-g. Although not shown here, the ex-
pansion by young versus aged naive Tg1 CD4 cells cul-
tured with Th1 or Th2 polarizing conditions were compa-
rable. When Tg1 Th1 and Th2 effectors are restimulated,
they secrete high levels of specific cytokines. Th1 effectors
secrete IL-2 and IFN-g, whereas Th2 effectors secrete IL-4,
IL-5, and a small amount of IL-2. To determine whether
clear polarization could occur with aged CD4 T cells, we
generated effectors from both young and aged CD4 T cells
in the presence of cytokines (including IL-2) and blocking
antibodies. When we restimulated Tg1 Th1 and Th2 effec-
tors after 4 d of culture, effectors generated from both
young and aged populations secreted similar levels of the
appropriate cytokines. Fig. 6 shows that Tg1 Th1 effectors
produced IL-2 and IFN-g and Tg1 Th2 effectors produced
IL-4 and IL-5 with no age-related deficiencies. These re-
sults demonstrate that aged naive Tg1 CD4 cells are just as
capable of differentiating into highly polarized Th1 and
Th2 effectors as young Tg1 cells, given the appropriate po-
larizing conditions and adequate amounts of IL-2.
Rescue of Polarized Effector Generation with IL-15. IL-15
acts by binding to a three-chain receptor composed of the
IL-2Rb and IL-2Rg chains and a unique a chain. To see if
there was any difference in the ability of IL-2 and IL-15 to
support effector generation of aged CD4 T cells, we tested
the ability of IL-15 to substitute for IL-2 in the differentia-
tion of young and aged Th1 and Th2 effectors. Polarized
effectors were generated in the presence of polarizing cy-
tokines and antibodies (IL-12 and anti–IL-4 for Th1 and
IL-4 and anti–IFN-g for Th2) alone, with exogenous IL-2,
or with exogenous IL-15. Fig. 7 A shows cytokine produc-
tion data from a representative experiment, whereas Fig. 7
B shows the mean percent increase 6 SE in cytokine pro-
duction in cultures generated with added IL-2 or IL-15
over that seen with polarizing cytokines alone for three
separate experiments. IL-2 and IFN-g production is from
Th1 effectors, and IL-4 and IL-5 production is from Th2
effectors after restimulation with Ag and APC. Th1 effec-
tors from CD4 T cells of young mice make high levels of
IL-2 and IFN-g regardless of whether IL-2 or IL-15 is
added. Aged Th1 effectors make enhanced levels of IL-2 (a
150% increase) when exogenous IL-2 is added, compared
Figure 5. Phenotype of young and aged Tg1 CD4 effectors. Effectors
were generated from young and aged Tg1 CD4 cells with DCEK-ICAM
APCs (2:1 T cell/APC) and PCCF alone (NO CYTOKINE EFFEC-
TORS) or with added optimum concentrations of exogenous IL-2, IL-4,
IL-7, or IL-15. (A) Day 4 young (open histograms) and aged (shaded his-
tograms) effectors were stained for CD4 and TCR transgene expression as
well as CD44, CD62L, and CD25. Naive Tg1 CD4 cells (bottom row)
and isotype controls (dashed gray lines) are also shown. (B) Day 4 young
(open histograms) and aged (shaded histograms) no cytokine and IL-2 ef-
fectors were stained for expression of IL-2R a, b, and g chains. All histo-
grams are gated on Tg1 CD4 cells. Data is representative of five experi-
ments.
Figure 6. Cytokine production by young and aged Th1 and Th2 effec-
tors. Effectors were generated from young and aged Tg1 CD4 cells with
DCEK-ICAM APCs (2:1 T cell/APC), PCCF, and Th1 or Th2 polariz-
ing cytokines and anticytokine antibodies (see Materials and Methods).
All supernatants (24 h) were collected from 3 3 105 day 4 effectors re-
stimulated with DCEK-ICAM and PCCF and assayed for IL-2, IL-4,
IL-5, and IFN-g. Data is representative of three experiments.1019 Haynes et al.
with a 70% increase when IL-15 is added; IFN-g produc-
tion by Th1 cells from aged mice is for the most part unaf-
fected by exogenous IL-2 or IL-15. Th2 effectors from
CD4 T cells of young mice produce IL-4 and IL-5, which
can be enhanced up to 100% when IL-2 is added. Impor-
tantly, the production of high levels of IL-4 and IL-5 by
aged Th2 effectors is uniquely IL-2 dependent (a 110% in-
crease for IL-4 and a 235% increase for IL-5) and cannot be
induced by the presence of IL-15 (a 0.7% increase for IL-4
and a 20% increase for IL-5).
The cell recoveries of the effectors generated in Fig. 7 A
are shown in Fig. 7 C. Both IL-2 and IL-15 can enhance
the expansion of young and aged Th1 effectors but have
little effect on Th2 cells, because the Th2 effectors expand
due to the presence of IL-4. These results indicate that
even though both IL-4 and IL-15 can induce high levels of
proliferation of aged Tg1 CD4 cells, other additional fac-
tors are necessary to induce differentiation into highly po-
larized Th1 or Th2 effectors in vitro. Fig. 7 D shows CD25
expression by the young and aged effectors from Fig. 7 A.
As expected, only the addition of IL-2 can increase CD25
expression by aged effectors (both Th1 and Th2) to the
levels seen on young effectors. Aged Th1 and Th2 effectors
generated with polarizing cytokines alone or in the pres-
ence of IL-15 express lower levels of CD25 compared with
young effectors.
Discussion
During a primary response, generation of large numbers
of CD4 effectors able to secrete high titers of cytokines is
critical in order to quickly clear the immunogen. Using a
Figure 7. IL-15 cannot substitute for IL-2 in promoting efficient Th1/Th2 differentiation of aged effectors. Young and aged Th1 and Th2 effectors
were generated without exogenous IL-2, with IL-2 (1IL-2; hatched bars), or with IL-15 (1IL-15; shaded bars) in addition to polarizing cytokines and
blocking antibodies. (A) Cytokine production by young (solid bars) and aged (hatched bars) cultures generated with no exogenous IL-2 (NONE), with
IL-2 (1IL-2), or with IL-15 (1IL-15). IL-2 and IFN-g production graphs are data from Th1 effectors; IL-4 and IL-5 production graphs are data from
Th2 effectors. All supernatants (24 h) were collected from 3 3 105 day 4 effectors restimulated with DCEK-ICAM and PCCF and assayed for IL-2, IL-
4, IL-5, and IFN-g. Data is representative of three experiments. (B) Percent increase in cytokine production by cultures with IL-2 or IL-15 above the
cultures with polarizing conditions alone. IL-2 and IFN-g production graphs are data from Th1 effectors; IL-4 and IL-5 production graphs are data from
Th2 effectors. Data are the means 6 SE of the three experiments represented in A. (C) Tg1 CD4 effector recovery from effectors generated in A. 106 na-
ive CD4 T cells were cultured for 4 d with DCECK-ICAM and PCCF plus polarizing cytokines alone (solid bars) or with IL-2 (hatched bars) or IL-15
(shaded bars). (D) CD25 expression by day 4 young (open histograms) and aged (shaded histograms) Th1 and Th2 effectors generated in A. Histograms
are gated on Tg1 CD4 T cells. Data is representative of three experiments.1020 IL-2 Can Reverse the Defect in Effector T Cells from Aged TCR-Tg Mice
TCR-Tg mouse model, we have found several profound
alterations in CD4 effector cell generation that are associ-
ated with aging, and our results suggest that the low pro-
duction of IL-2 by aged naive cells is largely (or totally) re-
sponsible for these deficiencies. Aged CD4 T cell defects
included lower production of IL-2, loss of late phase ex-
pansion, and failure to differentiate into effectors that ex-
press phenotypic markers associated with that stage and that
secrete high levels of cytokines. Importantly, provision of
exogenous IL-2 both supports the expansion and differenti-
ation of aged naive CD4 cells and leads to generation of ef-
fectors that themselves are capable of optimum IL-2 pro-
duction. Furthermore, we show here that whereas both IL-2
and IL-15 as well as IL-4 and IL-7 can enhance the expan-
sion of aged CD4 T cells, only IL-2 can support the effi-
cient generation of polarized Th2 effectors, indicating a
unique role for IL-2 signaling through the high affinity IL-2R
in effector development.
Aged Tg1 CD4 cells expand less than young cells during
the 5-d period of in vitro effector generation (Fig. 1, A–C).
The early stage of expansion (days 1–3) is quite similar in
both the young and aged cultures, whereas later expansion
(days 4 and 5) is three to five times greater in the cultures of
young cells. This is most dramatically observed by flow cy-
tometric analysis of CFSE-labeled young and aged Tg1
CD4 cells (Fig. 1 C), in which we can actually visualize
that the aged cells do not divide after day 3, whereas the
young cells continue dividing. This effect is mirrored in the
expansion of cells, which continues after day 3 in young
but not aged populations. Moreover, the aged CD4 effec-
tors expressed decreased levels of CD25 (IL-2Ra). We
suggest that the early stage of proliferation is more depen-
dent upon Ag-induced TCR stimulation, and the latter
stage is more dependent upon IL-2, which is present in
greater amounts in the young cultures. The phenotype of
the day 4 effectors generated from aged naive cells was be-
tween that of a naive cell and a day 4 effector from young
mice, i.e., the aged effector cells had a less differentiated
phenotype that had high levels of CD44 but did not sub-
stantially downregulate CD62L and did not upregulate
IL-2R (CD25) expression. This suggests that cytokines (IL-2
and perhaps others) acting midway (days 2–3) in the pri-
mary response (when IL-2 disappears from cultures of aged
cells) are required for full differentiation into effectors. Ef-
fectors generated from these Tg1 CD4 cells from aged
mice produced less IL-2, and the frequency of effector cells
secreting IL-2, as detected by intracellular staining, was also
significantly reduced in the aged, supporting dependence
on the continued presence of IL-2 for efficient effector
generation.
These results thus support a large impact of aging on
CD4 effector development but also suggest that the spec-
trum of deficiencies found in effector generation of aged
CD4 T cells may be attributable largely or totally to the de-
creased secretion of IL-2 upon initial TCR stimulation. In
vitro, IL-2 supports the progression of activated T cells
through the cell cycle, the regulation of the differentiation
of T cell effectors, and the differentiation of CD4 T cells so
they become susceptible to Fas/FasL-induced activation-
induced cell death (30–32). Although other cytokines that
signal through the gc chain may substitute for IL-2, IL-2 is
the only gc chain–binding cytokine produced when naive
CD4 T cells are stimulated in vitro and is thus solely re-
sponsible under these circumstances where no other T cells
are present and other cell populations are limited. There-
fore, the finding that IL-2 secretion by CD4 Tg1 cells
upon TCR stimulation is markedly reduced in the aged is
predicted to have profound effects on the generation of ef-
fector cells and the ensuing effector response. Moreover, as
IL-2 regulates its own receptor expression (33–35), the ef-
fects of any reduction in IL-2 production in the early stages
of an immune response may be amplified enormously. It
then becomes important to know whether these deficien-
cies may be overcome simply by the addition of IL-2 or
other cytokines or if other intrinsic defects in the effector
cells’ ability to respond to IL-2 are present.
When aged CD41 Tg1 effectors are generated in the
presence of IL-2 (IL-2 effectors, Th1 and Th2 effectors),
they become phenotypically (Fig. 4) and functionally (Figs.
5–7) similar to effectors derived from younger mice. In ad-
dition to upregulating CD44, they upregulate CD25 ex-
pression and downregulate CD62L. They also expand at
the same rate and to the same extent as seen in cultures of
young Tg1 cells (Fig. 2). When aged effectors generated in
the presence of IL-2 are restimulated with Ag/APC, they
secrete levels of cytokines that are the same as young effec-
tors (Figs. 5–7). Additionally, similar proportions of IL-2
effectors in both the young and aged populations are ac-
tively secreting IL-2 (Fig. 4), and similar amounts of cyto-
kines are secreted on a per-cell basis. These findings suggest
that the major defect in effector cell generation in the aged
is the inability to secrete sufficient IL-2 levels to sustain cell
expansion and induce further differentiation to fully func-
tional effector cells. However, the addition of sufficient
levels of IL-2 during effector cell generation abrogates
these age-related differences. Once adequately differenti-
ated effectors are generated, it is not surprising that the ef-
fector progeny are capable of high levels of cytokine pro-
duction, based on recent publications reporting the
heritability of differential gene methylation patterns (epige-
netic remodeling) that occurs during effector generation
(36–38). This model proposes that activation and effector
generation of T cells involves demethylation and increased
accessibility of the cytokine gene locus (IL-2 in this case) to
transcription factors as a consequence of signaling from the
appropriate cytokine receptor. This remodeling is perma-
nent and heritable, thus explaining our finding that aged
IL-2 effectors generated in the presence of high levels of
IL-2 can produce high levels of IL-2 upon restimulation.
Experiments to test this hypothesis on young and aged ef-
fectors are planned.
When IL-2 remains low during effector generation in
cultures of aged CD4 T cells, only a fraction of the poten-
tial effector generation is realized. It is not clear if this par-
tially activated population can later be recruited into the re-
sponding population, as a lack of IL-2 during effector cell1021 Haynes et al.
generation has been reported to lead to anergy in some
models (39, 40). The presence of a significant population of
nonresponding or poorly responding T cells in aged indi-
viduals is well documented (12, 19, 41–44), and these cells
have been shown to display a phenotype similar to the aged
no cytokine effectors generated in our model. Further-
more, in IL-22/2, IL-2Ra2/2, and IL-2b2/2 mice (45–
47), many CD4 T cells express an Ag-experienced pheno-
type but appear to be nonresponsive to TCR stimulation.
There is also impaired in vivo peripheral deletion of these
Ag-experienced cells in both models. This has lead to the
hypothesis that in the absence of IL-2 induced signals, stim-
ulation of T cells fails to activate the death pathway, which
leads to the accumulation of Ag-experienced anergic cells
in the periphery, and we suggest that this is what may be
occurring in aged individuals.
During an in vivo response, other cytokines that signal
through the gc chain may be present and could possibly re-
place IL-2 and restore function of aged naive cells. The ex-
periments shown in Fig. 3 demonstrate that other cytokines
that signal through the gc chain (IL-15, IL-4, and IL-7) can
indeed increase the proliferative capacity of naive aged Tg1
CD4 cells. It seems likely that these effects are via an IL-2–
independent mechanism that does not involve increased
IL-2 production or upregulation of IL-2Ra expression.
Most interesting, from a therapeutic viewpoint, is the effect
of IL-15. IL-15 was able to support not only enhanced ex-
pansion of aged CD4 T cells without IL-2Ra expression
but also development of Th1 polarized effectors. However,
although IL-2 addition allows aged CD4 T cells to develop
into polarized effectors under the influence of polarizing
cytokines, IL-15 is unable to support optimum develop-
ment of Th2 effectors. These data support the hypothesis
that IL-2, acting through the high affinity IL-2R, plays a
unique role in Th2 effector generation and that lower IL-2
production by aged CD4 T cells results in a defect in both
expansion of responding naive cells and efficient generation
of Th2-polarized effectors.
Recent reports have shown that adjuvants such as LPS,
poly I:C, and nonvertebrate DNA can induce type 1 IFN,
which then induces APCs to secrete IL-15 (48, 49). If these
adjuvants can induce adequate IL-15 levels in vivo, they
may be able to stimulate enhanced proliferation of activated
T cells in aged individuals, which could lead to the devel-
opment of more efficacious vaccines. Even though aged ef-
fectors generated in the presence of IL-15 in vitro are not
as differentiated as those generated in the presence of IL-2,
the increased expansion of these aged “IL-15 effectors”
may boost the in vivo aged immune response sufficiently to
gain an advantage over an invading pathogen. However,
based on our results, one might expect defects in genera-
tion of Th2 polarized effectors and in response to patho-
gens cleared by Th2-dependent mechanisms. Experiments
are currently underway in our laboratory to examine the in
vivo potential of this approach.
In conclusion, it is clear that the decline in IL-2 produc-
tion by naive CD4 T cells that occurs with aging has a dra-
matic negative impact in the generation of T cell effectors
in vitro. Assuming that such a decrease also occurs in vivo,
this would lead to decreased and ineffective responses, thus
helping to explain the increased incidence of mortality and
infection with aging. In fact, preliminary studies suggest
that aged naive CD4 T cells also respond poorly in vivo
(Haynes, L., and S.L. Swain, unpublished data). Moreover,
it is conceivable that any cell that partially undergoes a lim-
ited response and receives subthreshold signals from IL-2
may become anergic, and these anergic cells (which do not
undergo apoptosis) could potentially accumulate with ag-
ing and fill the peripheral immune system with nonrespon-
sive lymphocytes. However, the ability of exogenous IL-2
and other gc-binding cytokines to reverse the proliferative
defect of aged CD4 cells in vitro raises the possibility that
adjuvants that work to induce inflammatory cytokines (IL-
15 or other gc reacting cytokines) might boost the primary
response and restore effector generation in the elderly.
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